Related Experiment Video
Updated: Dec 2, 2025

09:21
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.9K
Transcriptomic profiles in Parkinson's disease
Lille Kurvits1,2, Freddy Lättekivi3, Ene Reimann4
1Department of Neurology and Neurosurgery, University of Tartu, Tartu 50406, Estonia.
Experimental Biology and Medicine (Maywood, N.J.)
|November 5, 2020
Summary
Parkinson's disease transcriptomics reveals limited overlap in gene expression between blood, skin, and brain tissues. Despite this, peripheral tissues show potential disease-specific changes, suggesting Parkinson's may be a multisystem disorder.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Transcriptomics aids Parkinson's disease (PD) research but brain tissue access is limited.
- Peripheral tissues like blood and skin offer alternative sources for PD molecular profiling.
Purpose of the Study:
- To profile and compare gene expression in blood and skin of PD patients versus controls.
- To meta-analyze existing transcriptomic data from PD brain and blood samples.
- To investigate PD as a potential multisystem disorder by examining peripheral tissues.
Main Methods:
- RNA-sequencing and RT-qPCR were used for blood and skin samples from 12 PD patients and 12 controls.
- Robust rank aggregation (RRA) method was applied for meta-analysis of previous PD transcriptomic data.
- Comparison of gene expression profiles across blood, skin, and post-mortem brain tissues.
Main Results:
- No overlapping differentially expressed genes or pathways were found between blood and skin in the current study.
- Meta-analysis identified significant gene expression changes in cortex, substantia nigra, and blood.
- Minimal overlap was observed between gene expression changes in different tissues, including skin and cortex.
Conclusions:
- Parkinson's disease shows limited shared transcriptomic signals across blood, skin, and brain tissues.
- Divergent gene expression profiles and transcriptomic noise may obscure common signals.
- Peripheral tissues exhibit potential PD-specific alterations, supporting the hypothesis of Parkinson's as a multisystem disorder.
More Related Videos
Related Concept Videos
Parkinson's Disease: Overview
1.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.4K
Neural Regulation
42.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.5K
Parkinson's Disease: Treatment
793
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
793

